Vaxdesign to deliver an artificial immune system prototype to support the development of medical countermeasures for biological threats. This will be done through three primary objectives: 1) generate…

Ended Definitive Contract Awarded Last action

Contract number
HDTRA109C0004
Awardee
Awarding agency
Obligated
$9,208,616

Award facts

Contract value 100% obligated
$9,208,616.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Orlando, FL 32826, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 $700,000
Change Order P00010 · Option period 2 $300,000
Other Administrative Action P00009 · No cost extension to option period 2. $0
Other Administrative Action P00008 · Option period 2 $1,000,000
Additional Work (new agreement, FAR part 6 applies) P00007 · Base period $2,077,258
Other Administrative Action P00006 · In vitro immune responses of biodefense vaccines R & D effort $0
Additional Work (new agreement, FAR part 6 applies) P00005 · In vitro immune responses of biodefense vaccines $0
Funding Only Action P00004 · In virtro immune responses of biodefense vaccines R & D effort. $1,000,000
Exercise an Option P00003 · In vitro immune responses of biodefense vaccines R & D effort. $1,000,000
Other Administrative Action P00002 · Base period $0
Supplemental Agreement for work within scope P00001 · In vitro immune responses of biodefense vaccines. $1,131,358
Original award $2,000,000
Show all 12

Description

Vaxdesign to deliver an artificial immune system prototype to support the development of medical countermeasures for biological threats. This will be done through three primary objectives: 1) generate high affinity in vitro primary human antibody response; 2) develop sensitive fluorescent-based microneutralization assays to assess AB functionality; and 3) test and evaluate modular immune in vitro construct (MIMIC) responses with various biodefense vaccine candidates.

Quick answers

Who was awarded contract HDTRA109C0004?

HDTRA109C0004 was awarded to Sanofi Pasteur Vaxdesign Corp by Defense Threat Reduction Agency (Department of Defense) on October 6, 2008.

How much is contract HDTRA109C0004 worth?

The government has obligated $9,208,616 on HDTRA109C0004.

Was contract HDTRA109C0004 competed?

The extent of competition for HDTRA109C0004 was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award